Intranuclear 3'-phosphoinositide metabolism and apoptosis protection in PC12 cells

Acta Biomedica

Volumn 78, Issue SUPPL. 1, 2007, Pages 113-119

  Martelli, Alberto M ^a,b   Evangelisti, Camilla ^a   Billi, Anna Maria ^a   Manzoli, Lucia ^a   Papa, Veronica ^a   Cocco, Lucio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b CNR   (Italy)

Author keywords

Akt; Apoptosis; Nucleus; PI3K; PtdIns (3,4,5)P3

Indexed keywords

CENTG1 PROTEIN, RAT; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOENZYME; NERVE GROWTH FACTOR; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5-TRIPHOSPHATE; POLYPHOSPHOINOSITIDE; PROTEIN KINASE B; RAS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL; APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CELL NUCLEUS; CELL STRAIN; CYTOLOGY; DRUG EFFECT; METABOLISM; PHYSIOLOGY; RAT; SECOND MESSENGER;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL NUCLEUS; GTP-BINDING PROTEINS; ISOENZYMES; MODELS, BIOLOGICAL; NERVE GROWTH FACTOR; PC12 CELLS; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHATIDYLINOSITOLS; PROTO-ONCOGENE PROTEINS C-AKT; RAS PROTEINS; RATS; SECOND MESSENGER SYSTEMS;

EID: 34347255727     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Martin TE. Phosphoinositide lipids as signaling molecules: common themes for signal transduction, cytoskeletal regulation, and membrane trafficking. Annu Rev Cell Dev Biol 1998; 14: 231-64.
2. Payrastre B, Missy K, Giuriato S, Bodin S, Plantavid M, Gratacap M. Phosphoinositides: key players in cell signalling, in time and space. Cell Signal 2001; 13: 377-87.
3. Vanhaesebroeck B, Waterfield MD. Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 1999; 253: 239-54.
4. Cantrell DA. Phosphoinositide 3-kinase signalling pathways. J Cell Sci 2001; 114: 1439-45.
5. Roymans R, Slegers H. Phosphatidylinositol 3-kinases in tumor progression. Eur J Biochem 2001; 268: 487-98.
6. Hanada M, Feng J, Hemmings BA. Structure, regulation and function of PKB/AKT-a major therapeutic target. Biochim Biophys Acta 2004; 1697: 3-16.
7. Cocco L, Martelli AM, Gilmour RS, Rhee SG, Manzoli FA. Nuclear phospholipase C and signaling. Biochim Biophys Acta 2001; 1530: 1-14.
8. Irvine RF. Nuclear lipid signalling. Nat Rev Mol Cell Biol 2003; 4: 349-60.
9. Martelli AM, Manzoli L, Cocco L. Nuclear inositides: facts and perspectives. Pharmacol Ther 2004; 101: 47-64.
10. Neri LM, Borgatti P, Capitani S, Martelli AM. The nuclear phosphoinositide 3-kinase/AKT pathway: a new second messenger system. Biochim Biophys Acta 2002; 1584: 73-80.
11. Vanhaesebroeck B, Leevers SJ, Ahmadi K, et al. Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 2001; 70: 535-602.
12. Sansal I, Sellers WR. The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 2004; 22: 2954-63.
13. Parsons S. Human cancer, PTEN and the PI-3 kinase pathway. Semin Cell Dev Biol 2004; 15: 171-6.
14. Backers K, Blero D, Paternotte N, Zhang J, Erneux C. The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases. Adv Enzyme Regul 2003; 43: 15-28.
15. Foster FM, Traer CJ, Abraham SM, Fry MJ. The phosphoinositide (PI) 3-kinase family. J Cell Sci 2003; 116: 3037-40.
16. Oudit GY, Sun H, Kerfant BG, Crackower MA, Penninger JM, Backx PH. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 2004; 37: 449-71.
17. Brazil DP, Yang ZZ, Hemmings BA. Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem Sci 2004; 29: 233-42.
18. Mora A, Komander D, van Aalten DM, Alessi DR. PDK1, the master regulator of AGC kinase signal transduction. Semin Cell Dev Biol 2004; 15: 161-70.
19. Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, Gonzalez-Baron M PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 2004; 30: 193-204.
20. Martelli AM, Tabellini G, Bortul R, et al. Involvement of the phosphoinositide 3-kinase/Akt signaling pathway in the resistance to therapeutic treatments of human leukemias. Histol Histopathol 2005; 20: 239-52.
21. Tanaka K, Horiguchi K, Yoshida T, et al. Evidence that a phosphatidylinositol 3,4,5-trisphosphate-binding protein can function in nucleus. J Biol Chem 1999; 274: 3919-22.
22. Neri LM, Milani D, Bertolaso L, Stroscio M, Bertagnolo V, Capitani S. Nuclear translocation of phosphatidylinositol 3-kinase in rat pheochromocytoma PC 12 cells after treatment with nerve growth factor. Cell Mol Biol 1994; 40: 619-26.
23. Collins JM, Foster KA. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 1987; 70: 1233-44.
24. Bertagnolo V, Neri LM, Marchisio M, Mischiati C, Capitani S. Phosphoinositide 3-kinase activity is essential for all-trans-retinoic acid-induced granulocytic differentiation of HL-60 cells. Cancer Res 1999; 59: 542-6.
25. Neri LM, Marchisio M, Colamussi ML, Bertagnolo V. Monocytic differentiation of HL-60 cells is characterized by the nuclear translocation of phosphatidylinositol 3-kinase and of definite phosphatidylinositol-specific phospholipase C isoforms. Biochem Biophys Res Commun 1999; 259: 314-20.
26. Ye K, Hurt KJ, Wu FY, et al. Pike. A nuclear GTPase that enhances PI3kinase activity and is regulated by protein 4.1N. Cell 2000; 103: 919-30.
27. Ye K, Aghdasi B, Luo HR, et al. Phospholipase C 21 is a physiological guanine nucleotide exchange factor for the nuclear GTPase PIKE. Nature 2002; 415: 541-4.
28. Bae SS, Lee YH, Chang JS, et al. Src homology domains of phospholipase C p1 inhibit nerve growth factor-induced differentiation of PC12 cells. J Neurochem 1998; 71: 178-85.
29. rd. Regulation of the FoxO family of transcription factors by phosphatidylinositol-3 kinaseactivated signaling. Arch Biochem Biophys 2002; 403: 292-8.
30. Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 2002; 14: 381-95.
31. Downward J. PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol 2004; 15: 177-182.
32. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C. PI3K/Akt and apoptosis: size matters. Oncogene 2003; 22: 8983-98.
33. Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 1976; 73: 2424-8.
34. Deshmukh M, Johnson EM Jr. Programmed cell death in neurons: focus on the pathway of nerve growth factor deprivation-induced death of sympathetic neurons. Mol Pharmacol 1997; 51: 897-906.
35. Patapoutian A, Reichardt LF. Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol 2001; 11: 272-80.
36. Neri LM, Martelli AM, Borgatti P, Colamussi ML, Marchisio M, Capitani S. Increase in nuclear phosphatidylinositol 3-kinase activity and phosphatidylinositol (3,4,5) trisphosphate synthesis precede PKC-sstranslocation to the nucleus of NGF-treated PC12 cells. FASEB J 1999; 13: 2299-310.
37. Ahn JY, Rong R, Liu X, Ye K. PIKE/nuclear PI 3-kinase signaling mediates the antiapoptotic actions of NGF in the nucleus. EMBO J 2004; 23: 3995-4006.
38. Ramaswamy S, Nakamura N, Vazquez F, et al. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/ Akt pathway. Proc Natl Acad Sci USA 1999; 96: 2110-2115.
39. Borgatti P, Martelli AM, Tabellini G, Bellacosa A, Capitani S, Neri LM. Threonine 308 phosphorylated form of Akt translocates to the nucleus of PC12 cells under nerve growth factor stimulation and associates with the nuclear matrix protein nucleolin. J Cell Physiol 2003; 196: 79-88.
40. Anh JY, Liu X, Cheng D, et al. Nucleophosmin/B23, a nuclear PI(3,4,5)P3 rceptor, mediates the antiapoptotic actions of NGF by inhibiting CAD. Mol Cell 2005; 18: 435-45.
41. Zhou G, Seibenhener ML, Wooten MW. Nucleolin is a protein kinase C-rrsubstrate. Connection between cell surface signaling and nucleus in PC12 cells. J Biol Chem 1997; 272: 31130-7.
42. Ginisty H, Sicard H, Roger B, Bouvet P. Structure and functions of nucleolin. J Cell Sci 1999; 112: 761-72.
43. Sengupta TK, Bandyopadhyay S, Fernandes DJ, Spicer EK. Identification of nucleolin as an AU-rich element binding protein involved in bcl-2 mRNA stabilization. J Biol Chem 2004; 279: 10855-63.
44. Otake Y, Sengupta TK, Bandyopadhyay S, Spicer EK, Fernandes DJ. Retinoid-induced apoptosis in HL-60 cells is associated with nucleolin down-regulation and destabilization of Bcl-2 mRNA. Mol Pharmacol 2005; 67: 319-26.
45. Mi Y, Thomas SD, Xu X, Casson LK, Miller DM, Bates PJ. Apoptosis in leukemia cells is accompanied by alterations in the levels and localization of nucleolin. J Biol Chem 2003; 278: 8572-9.
46. Divecha N, Banfic H, Irvine RF. Inositides and the nucleus and inositides in the nucleus. Cell 1993; 74: 405-7.
47. Payrastre B, van Bergen en Henegouwen PM, Breton M, et al. Phosphoinositide kinase, diacylglycerol kinase, and phospholipase C activities associated to the cytoskeleton. effect of epidermal growth factor. J Cell Biol 1991; 115: 121-8.
48. Cheng MK, Shearn A. The direct interaction between ASH2, a Drosophila trithorax group protein, and SKTL, a nuclear phosphatidylinositol 4-phosphate 5-kinase, implies a role for phosphatidylinositol 4,5-bisphosphate in maintaining transcriptionally active chromatin. Genetics 2004; 167: 1213-23.
49. Krylova IN, Sablin EP, Moore J, et al. Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 2005; 120: 343-55.
50. Vincent AM, Mobley BC, Hiller A, Feldman EL. IGF-I prevents glutamate-induced motor neuron programmed cell death. Neurobiol Dis 2004; 16: 407-16.
51. Widlak P, Garrard WT. Discovery regulation, and action of the major apoptotic nucleases DFF40/CAD and endonuclease G. J Cell Biochem 2005; 94. 1078-87.